What is a characteristic feature of apoptosis?
Corrugated collagenous rings surrounding lymphocytes and plasma cells in the walls of inflammatory cysts are called?
Which of the following is a vasoconstricting mediator?
Which of the following conditions follows an autosomal dominant inheritance pattern?
Which of the following pigment is deposited in aging heart?
Which one of the following is NOT a characteristic feature of an autosomal recessive disorder?
Metastatic calcification predominantly affects which of the following organs, except?
Which of the following is characteristic of Langerhans cells?
Which of the following substances is NOT secreted by Eosinophils?
Multifactorial inheritance is most likely to play a role in which of the following conditions?
Explanation: **Explanation:** **Apoptosis** is a form of programmed cell death characterized by a tightly regulated suicide program [1]. The hallmark of apoptosis is that the **cell membrane remains intact** throughout the process. This integrity prevents the leakage of intracellular contents (like lysosomal enzymes) into the extracellular space, which is why apoptosis—unlike necrosis—does **not** elicit an inflammatory response [2]. The cell eventually fragments into membrane-bound "apoptotic bodies" which are cleared by phagocytes [2]. **Analysis of Incorrect Options:** * **B. Cytoplasmic eosinophilia:** While seen in apoptosis due to the loss of cytoplasmic RNA and protein denaturation, it is a non-specific feature also seen prominently in **necrosis** [3] (e.g., "coagulative necrosis"). * **C. Nuclear moulding:** This is a cytological feature where nuclei of adjacent cells press against each other, distorting their shapes [4]. It is characteristic of certain malignancies, most notably **Small Cell Carcinoma of the lung**, not apoptosis. * **D. Cell swelling:** This is the hallmark of **reversible cell injury** and **necrosis** (oncosis) [3]. In contrast, apoptosis is characterized by **cell shrinkage** (pyknosis). **NEET-PG High-Yield Pearls:** * **Most characteristic feature:** Chromatin condensation (pyknosis) and fragmentation (karyorrhexis). * **Molecular Marker:** Presence of **Phosphatidylserine** on the outer leaflet of the cell membrane (the "eat-me" signal) [2]. * **DNA Pattern:** "Step-ladder pattern" on gel electrophoresis due to internucleosomal cleavage by endonucleases. * **Caspases:** The executioners of apoptosis; Caspase-3 is the common executioner for both intrinsic and extrinsic pathways [5]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 63-64. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 67-69. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 53. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 310. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 64-65.
Explanation: ### Explanation **Correct Answer: B. Hyaline bodies (Rushton bodies)** In the context of oral pathology and inflammatory cysts (such as radicular cysts), **Hyaline bodies**, also known as **Rushton bodies**, are characteristic microscopic findings. They appear as eosinophilic, linear, curved, or "corrugated" glassy structures. They are typically found within the epithelial lining or the underlying connective tissue wall, often surrounded by chronic inflammatory cells like lymphocytes and plasma cells. While their exact origin is debated, they are generally considered to be a secretory product of odontogenic epithelium. **Analysis of Incorrect Options:** * **A. Ruston bodies:** This is a common distractor. The correct eponym is **Rushton bodies** (with an 'h'). While phonetically similar, "Ruston" is technically incorrect in a formal examination context. * **C. Howell-Jolly bodies:** These are small, round, purple-staining nuclear remnants (DNA) found inside **red blood cells**. They are typically seen in patients with splenic atrophy or post-splenectomy. * **D. Pappenheimer bodies:** These are abnormal granules of **iron** (ferritin aggregates) found inside red blood cells, visualized with Wright or Giemsa stains. They are characteristic of sideroblastic anemia. **High-Yield Clinical Pearls for NEET-PG:** * **Rushton Bodies:** Exclusively found in **odontogenic cysts** (most commonly Radicular and Dentigerous cysts). They are brittle and may show a "cracked" appearance. * **Civatte Bodies:** Found in Lichen Planus (apoptotic keratinocytes). * **Verocay Bodies:** Found in Schwannomas (Antoni A areas). * **Schaumann Bodies:** Laminated calcium/protein concretions found in Sarcoidosis.
Explanation: **Explanation:** The question tests your knowledge of arachidonic acid metabolites (eicosanoids) and their physiological roles in inflammation and vascular tone [1]. **Correct Answer: B. Thromboxane-A2 (TXA2)** Thromboxane-A2 is synthesized by platelets via the cyclooxygenase (COX) pathway. It is a potent **vasoconstrictor** and a powerful **platelet aggregator** [1]. Its primary physiological role is to promote hemostasis by narrowing blood vessels and facilitating the formation of a platelet plug [2]. **Analysis of Incorrect Options:** * **A. Prostacyclin (PGI2):** Produced by vascular endothelium, it is the functional antagonist to TXA2. It causes **vasodilation** and inhibits platelet aggregation [1], [2]. * **C. PGD2:** Along with PGE2 and PGF2α, PGD2 is a major prostaglandin involved in inflammation. It primarily causes **vasodilation** and increases vascular permeability [1]. * **D. Lipoxins (LXA4, LXB4):** These are products of the lipoxygenase pathway. Unlike prostaglandins, lipoxins are **anti-inflammatory** mediators that inhibit leukocyte recruitment and promote the resolution of inflammation [1]. They generally cause vasodilation (e.g., via stimulating NO release). **NEET-PG High-Yield Pearls:** * **The "Yin-Yang" Relationship:** Remember the balance between **TXA2** (Vasoconstrictor/Aggregator) and **PGI2** (Vasodilator/Anti-aggregator) [1], [2]. An imbalance is often implicated in thrombosis and myocardial infarction. * **Aspirin's Mechanism:** Low-dose aspirin irreversibly inhibits COX-1 in platelets, reducing TXA2 levels. * **Other Vasoconstrictors in Pathology:** Leukotrienes (C4, D4, E4) also cause vasoconstriction (and bronchospasm), but among the options provided, TXA2 is the classic eicosanoid vasoconstrictor [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 94-96. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, p. 130.
Explanation: **Explanation:** **Hereditary Spherocytosis (HS)** is the correct answer because it follows an **autosomal dominant (AD)** inheritance pattern in approximately 75% of cases. The underlying pathophysiology involves mutations in genes encoding red blood cell membrane proteins, most commonly **Ankyrin**, followed by Spectrin, Band 3, and Protein 4.2 [1]. These defects lead to a loss of membrane surface area, forcing the RBCs to assume a spherical shape (spherocytes), which are then sequestered and destroyed in the spleen [1], [2]. **Analysis of Incorrect Options:** * **Albinism (Oculocutaneous Albinism):** This is a classic example of an **autosomal recessive (AR)** disorder, typically involving a deficiency in the enzyme tyrosinase. * **Sickle Cell Anemia:** This is an **autosomal recessive** hemoglobinopathy caused by a point mutation in the β-globin chain (glutamic acid replaced by valine at the 6th position). * **Thalassemia:** Both Alpha and Beta thalassemias are inherited in an **autosomal recessive** fashion, characterized by reduced synthesis of globin chains. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for AD disorders:** "Very Powerful DOMINANT Father" (Von Willebrand, Polycystic kidney, Dystrophia myotonica, Osteogenesis imperfecta, Marfan, Intermittent porphyria, Noonan, Achondroplasia, Neurofibromatosis, Tuberous sclerosis). * **Diagnostic Gold Standard for HS:** Eosin-5-maleimide (EMA) binding test (Flow cytometry) is now preferred over the traditional Osmotic Fragility Test [2]. * **Key Lab Finding:** Elevated **MCHC** (Mean Corpuscular Hemoglobin Concentration) is a highly specific marker for Hereditary Spherocytosis [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 640-641. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 597-598.
Explanation: **Explanation:** **Lipofuscin** is the correct answer. Known as the **"wear-and-tear"** or **"aging"** pigment, it is an insoluble brownish-yellow granular intracellular material [1]. 1. **Mechanism:** Lipofuscin is a product of **lipid peroxidation** of polyunsaturated lipids of subcellular membranes. It represents the indigestible residues of autophagic vacuoles. As cells age, these granules accumulate within lysosomes, particularly in permanent cells that do not undergo division, such as **myocardial fibers** and **neurons** [1]. In the heart, extensive deposition leads to a condition known as **"Brown Atrophy."** **Analysis of Incorrect Options:** * **A. Hemosiderin:** This is a golden-yellow to brown pigment derived from hemoglobin [2]. It represents large aggregates of ferritin and is typically seen in areas of hemorrhage or systemic iron overload (hemosiderosis/hemochromatosis), not as a physiological aging process [2], [4]. * **C. Ceruloplasmin:** This is a plasma protein (alpha-2 globulin) responsible for carrying copper in the blood. It is not a tissue pigment. Deficiency of ceruloplasmin is associated with Wilson’s disease [3]. **High-Yield Facts for NEET-PG:** * **Appearance:** On H&E stain, Lipofuscin appears as fine, yellow-brown perinuclear granules [1]. * **Significance:** It is not toxic to the cell but serves as a hallmark of free radical injury and lipid peroxidation. * **Staining:** Lipofuscin is **Sudanophilic** (stains with Sudan Black B) and may show autofluorescence. * **Differentiation:** Unlike Hemosiderin, Lipofuscin is **negative for Prussian Blue** (Perl’s) stain [4]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 75. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 75-76. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 394-395. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 854-855.
Explanation: Explanation: In **Autosomal Recessive (AR) disorders**, both alleles of a gene must be mutated for the disease to manifest [1]. This leads to a highly uniform clinical presentation among affected siblings because the genetic defect is typically a complete "loss of function" (often enzymatic) [2,3]. **1. Why Option A is the Correct Answer:** **Wide variation in phenotype** is a hallmark of **Autosomal Dominant (AD)** disorders, not AR. In AD conditions, phenomena like *variable expressivity* and *reduced penetrance* cause family members with the same mutation to show different degrees of severity. In contrast, AR disorders usually show low clinical variability within a family. **2. Analysis of Incorrect Options:** * **Option B:** Since the gene is located on an autosome (non-sex chromosome), the inheritance is independent of sex; thus, **males and females are affected equally**. * **Option C:** For a child to be affected (homozygous recessive), both parents must contribute a mutant allele. Usually, parents are asymptomatic **heterozygous carriers** [1]. * **Option D:** AR disorders typically appear in a single generation (among siblings) rather than across multiple generations. This is described as a **horizontal pattern** on a pedigree. **NEET-PG High-Yield Pearls:** * **Enzyme vs. Structural:** Most AR disorders involve **enzyme deficiencies** (e.g., PKU, Alkaptonuria, Lysosomal storage diseases) [2,3]. Most AD disorders involve **structural proteins** (e.g., Marfan syndrome, Osteogenesis Imperfecta) or receptors [2]. * **Consanguinity:** The risk of AR disorders increases significantly in consanguineous marriages [1]. * **Recurrence Risk:** If both parents are carriers, the risk of having an affected child is **25%** for each pregnancy [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 53-54. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 57-58. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 150-151.
Explanation: **Explanation:** **Metastatic calcification** occurs in normal tissues due to hypercalcemia (elevated serum calcium levels). It predominantly affects organs that have an **internal alkaline environment**, as calcium salts preferentially precipitate in alkaline conditions [1]. **Why Pancreas is the Correct Answer:** The pancreas is not a primary site for metastatic calcification. While the pancreas produces alkaline bicarbonate, this is secreted into the pancreatic ducts (external environment). Intracellularly, the pancreas does not maintain the specific acid-base gradient required to trigger systemic metastatic calcification. Note: *Dystrophic* calcification can occur in the pancreas following chronic pancreatitis or fat necrosis, but that is a different process involving damaged tissue. **Analysis of Other Options:** * **Lungs:** During respiration, the excretion of $CO_2$ creates a relative alkalinity in the pulmonary parenchyma, making it a classic site for metastatic calcification [1]. * **Kidneys:** The excretion of $H^+$ ions into the urine creates an internal alkaline environment in the renal tubular cells, leading to **nephrocalcinosis** [1]. * **Media of Arteries:** Systemic arteries carry oxygenated blood with lower $CO_2$ tension compared to veins, maintaining a relative alkalinity that favors calcium deposition [1]. * **Stomach (Gastric Mucosa):** (Often tested) Like the kidneys, the stomach secretes $HCl$ into the lumen, leaving the epithelial cells alkaline and prone to calcification [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Sites of Metastatic Calcification:** "Lungs, Kidneys, Stomach, and Systemic Arteries" (Mnemonic: **K**idney, **A**rteries, **S**tomach, **L**ungs – **KASL**) [1]. * **Mechanism:** Deposition of calcium hydroxyapatite crystals in normal tissues due to hypercalcemia (e.g., Hyperparathyroidism, Vitamin D toxicity, Bone metastasis) [1]. * **Morphology:** On H&E stain, it appears as **basophilic** (blue-purple), amorphous granular clumps [1]. * **Dystrophic vs. Metastatic:** Dystrophic occurs in **dead/dying** tissue with **normal** serum calcium; Metastatic occurs in **normal** tissue with **elevated** serum calcium [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 76-77.
Explanation: Langerhans cells (LCs) are specialized dendritic cells found primarily in the stratum spinosum of the epidermis [2], [3]. They function as antigen-presenting cells (APCs) that capture antigens and migrate to regional lymph nodes to initiate an immune response [2]. **Why Option D is Correct:** The hallmark ultrastructural feature of Langerhans cells is the **Birbeck granule**. Under electron microscopy, these are pentalaminar, rod-shaped cytoplasmic organelles [1]. They often exhibit a dilated terminal end, giving them a classic **"tennis racquet"** appearance [1]. These granules contain the protein **Langerin (CD207)**, which is involved in the endocytosis of pathogens [1]. **Analysis of Incorrect Options:** * **Option A (Badminton racquet appearance):** This is a distractor. While Birbeck granules are described as "tennis racquets," the term "badminton racquet" is not standard medical terminology for these cells. * **Option B (CD100a):** This is incorrect. The specific marker for Langerhans cells is **CD1a** (along with S100 and CD207/Langerin). CD100 is a different molecule (Semaphorin 4D) not used as a diagnostic marker for these cells. * **Option C (MPO +):** Myeloperoxidase (MPO) is a marker for the myeloid lineage, specifically **neutrophils** and their precursors. It is used to diagnose Acute Myeloid Leukemia (AML) and is negative in Langerhans cells. **High-Yield Clinical Pearls for NEET-PG:** * **Langerhans Cell Histiocytosis (LCH):** A neoplastic proliferation of these cells. On biopsy, cells show "coffee-bean" nuclei (grooved nuclei) [1]. * **Immunohistochemistry (IHC):** LCH cells are characteristically **S100+**, **CD1a+**, and **Langerin (CD207)+** [1]. * **Electron Microscopy:** Still considered the gold standard for identifying Birbeck granules, though IHC for Langerin has largely replaced it in clinical practice [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 629-630. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, p. 200. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Skin, p. 1144.
Explanation: ### Explanation The correct answer is **B. Hydrolytic enzyme**. **1. Why Hydrolytic Enzyme is the correct answer:** Eosinophils are specialized granulocytes primarily involved in parasitic infections and allergic reactions. While they contain lysosomes, they **do not** typically secrete significant amounts of hydrolytic enzymes (like acid hydrolases) into the extracellular space as their primary mode of action. Hydrolytic enzymes are more characteristic of **Macrophages** and **Neutrophils**, which use them for intracellular digestion within phagolysosomes [1]. **2. Analysis of Incorrect Options:** * **A. Major Basic Protein (MBP):** This is the most abundant protein in eosinophilic granules. It is highly toxic to helminths (parasites) and causes degranulation of mast cells and basophils. * **C. Reactive Form of Oxygen (ROS):** Like neutrophils, eosinophils undergo a "respiratory burst" via the NADPH oxidase system, producing superoxide radicals and hydrogen peroxide to kill invading pathogens. * **D. Eosinophilic Chemotactic Factor (ECF):** Eosinophils can release factors that recruit more eosinophils to the site of inflammation, creating a positive feedback loop in allergic and parasitic responses. **3. NEET-PG High-Yield Clinical Pearls:** * **Granule Content:** Eosinophil granules contain **Major Basic Protein (MBP)**, **Eosinophil Cationic Protein (ECP)**, and **Eosinophil Peroxidase (EPO)**. MBP is the hallmark protein. * **Charcot-Leyden Crystals:** These are hexagonal, bipyramidal crystals found in sputum (asthma) or stool (parasitic infections), formed from the breakdown of eosinophil membrane proteins (**Galectin-10**). * **Eosinophilia Causes:** Remember the mnemonic **NAACP**: **N**eoplasia, **A**llergy/Asthma, **A**ddison’s disease, **C**onnective tissue disorders, **P**arasites [2]. * **Staining:** Eosinophils have a characteristic **bilobed nucleus** and granules that stain bright red/pink with acidic dyes like Eosin. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 91-92. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 592.
Explanation: **Explanation:** **Multifactorial inheritance** refers to conditions caused by the combined effects of multiple genes (polygenic) and environmental factors. These disorders do not follow classic Mendelian patterns and often exhibit a "threshold effect." **Why Cleft Lip is Correct:** Cleft lip (with or without cleft palate) is a classic example of a multifactorial malformation [2]. Its occurrence depends on the additive effect of several risk genes combined with environmental triggers (e.g., maternal smoking, folate deficiency, or alcohol use during pregnancy) [1]. Other common examples include neural tube defects, congenital heart disease, and pyloric stenosis [2]. **Analysis of Incorrect Options:** * **B. Marfan’s Syndrome:** This is an **Autosomal Dominant** disorder caused by a mutation in the *FBN1* gene on chromosome 15, which encodes fibrillin-1. It follows a clear Mendelian inheritance pattern. * **C. Down’s Syndrome:** This is a **Cytogenetic (Chromosomal)** disorder, most commonly caused by Trisomy 21 (nondisjunction) [2]. It is not inherited through gene-environment interactions but results from a numerical chromosomal aberration. * **D. Erythroblastosis Fetalis:** This is an **Alloimmune** condition (Type II Hypersensitivity) occurring due to Rh incompatibility between an Rh-negative mother and an Rh-positive fetus. It is an acquired immunological phenomenon, not a genetic inheritance pattern. **High-Yield Clinical Pearls for NEET-PG:** * **Recurrence Risk:** In multifactorial inheritance, the risk of recurrence is higher if more than one close relative is affected or if the index case has a severe form of the disease. * **Threshold Model:** The disease manifests only when the combined genetic and environmental liability exceeds a specific threshold. * **Common Examples:** Diabetes mellitus, Hypertension, Schizophrenia, and Gout are all multifactorial "adult-onset" diseases frequently tested [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 95-96. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 92-93. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 47-48.
Cell Injury and Cell Death
Practice Questions
Adaptations of Cellular Growth
Practice Questions
Accumulations and Deposits
Practice Questions
Acute and Chronic Inflammation
Practice Questions
Tissue Repair and Wound Healing
Practice Questions
Hemodynamic Disorders
Practice Questions
Genetic Disorders
Practice Questions
Environmental Pathology
Practice Questions
Nutritional Diseases
Practice Questions
Molecular Basis of Disease
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free